|
US7611713B2
(en)
|
1993-03-05 |
2009-11-03 |
Pharmexa Inc. |
Inducing cellular immune responses to hepatitis B virus using peptide compositions
|
|
US20040096445A1
(en)
*
|
1999-06-30 |
2004-05-20 |
John Sidney |
Subunit vaccines with A2 supermotifs
|
|
US9266930B1
(en)
|
1993-03-05 |
2016-02-23 |
Epimmune Inc. |
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
|
|
WO2001021189A1
(en)
*
|
1999-07-19 |
2001-03-29 |
Epimmune Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
|
EP1230268B1
(en)
|
1999-11-18 |
2009-10-14 |
Pharmexa Inc. |
Heteroclitic analogs of class i epitopes
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
EP1239866A4
(en)
*
|
1999-12-10 |
2005-02-09 |
Epimmune Inc |
INDUCTION OF HER2 / NEU CELLULAR IMMUNE RESPONSES USING PEPTIDE AND NUCLEIC ACID-CONTAINING COMPOSITIONS
|
|
US7462354B2
(en)
|
1999-12-28 |
2008-12-09 |
Pharmexa Inc. |
Method and system for optimizing minigenes and peptides encoded thereby
|
|
WO2001074847A2
(en)
*
|
2000-03-30 |
2001-10-11 |
The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services |
T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer
|
|
US20030175247A1
(en)
*
|
2000-05-12 |
2003-09-18 |
Michael Salgaller |
Method to increase class I presentation of exogenous antigens by human dendritic cells
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
JP5355839B2
(ja)
|
2001-10-23 |
2013-11-27 |
ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． |
Ｐｓｍａ抗体およびタンパク質マルチマー
|
|
GB0203420D0
(en)
|
2002-02-13 |
2002-04-03 |
Oxford Biomedica Ltd |
Peptide
|
|
GB0203419D0
(en)
|
2002-02-13 |
2002-04-03 |
Oxford Biomedica Ltd |
Peptide
|
|
PT1620456E
(pt)
*
|
2003-04-18 |
2014-04-15 |
Biotech Synergy Inc |
Péptidos antigénicos hla-a2 associados a tumor e suas composições
|
|
TWI262192B
(en)
*
|
2003-07-01 |
2006-09-21 |
Univ Nat Taiwan |
Labeling peptide for nasopharyngeal carcinoma (NPC) cells
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
|
JP2007277092A
(ja)
*
|
2004-06-17 |
2007-10-25 |
Univ Kurume |
前立腺関連抗原由来ｈｌａ−ａ２結合性ペプチド
|
|
EP1840133A1
(en)
*
|
2006-03-29 |
2007-10-03 |
Global Biotech Development Corp. Ltd. |
New immunomodulating oligopeptides
|
|
WO2008054540A2
(en)
|
2006-05-18 |
2008-05-08 |
Pharmexa Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
US8282938B2
(en)
*
|
2008-11-28 |
2012-10-09 |
National Institute Of Infectious Diseases |
Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain
|
|
EP2391635B1
(en)
*
|
2009-01-28 |
2017-04-26 |
Epimmune Inc. |
Pan-dr binding polypeptides and uses thereof
|
|
EP2569633B1
(en)
*
|
2010-05-14 |
2016-02-10 |
The General Hospital Corporation |
Compositions and methods of identifying tumor specific neoantigens
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
KR20230076867A
(ko)
|
2013-12-20 |
2023-05-31 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신생항원 백신과의 병용 요법
|
|
WO2015130488A2
(en)
|
2014-02-28 |
2015-09-03 |
Immunotope, Inc. |
Mhc class i associated peptides for prevention and treatment of hepatitis b virus infection
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
EP3234130B1
(en)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Methods for profiling the t-cell- receptor repertoire
|
|
IL294183B2
(en)
|
2015-05-20 |
2023-10-01 |
Dana Farber Cancer Inst Inc |
shared neoantigens
|
|
CN110022894B
(zh)
|
2016-10-07 |
2024-01-19 |
恩特罗姆公司 |
用于癌症疗法的免疫原性化合物
|
|
WO2018065623A2
(en)
*
|
2016-10-07 |
2018-04-12 |
Enterome |
Immunogenic compounds for cancer therapy
|
|
WO2018065628A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
KR20190129032A
(ko)
|
2016-12-28 |
2019-11-19 |
인벡스, 인크. |
인플루엔자 백신
|
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
CA3058807A1
(en)
|
2017-04-03 |
2018-10-11 |
Biontech Us Inc. |
Protein antigens and uses thereof
|
|
NL2019814B1
(en)
*
|
2017-10-26 |
2019-05-06 |
Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis |
Methods for producing a MHC multimer.
|
|
TW201930340A
(zh)
|
2017-12-18 |
2019-08-01 |
美商尼恩醫療公司 |
新抗原及其用途
|
|
HRP20230007T1
(hr)
|
2018-04-11 |
2023-03-03 |
Enterome S.A. |
Antigenski peptidi, namijenjeni sprječavanju i liječenju raka
|
|
MX2020014243A
(es)
|
2018-06-19 |
2021-05-12 |
Biontech Us Inc |
Neoantigenos y usos de los mismos.
|